Hemato-Oncology-23-Myelodysplastic Syndrome-Diagnosis
HEMATO-ONCOLOGY PART-23 Welcome to the twenty third part of a series on Hemato-oncology. Question: Dr. Chiragbhai, thank you for explaining us re CLL. It was interesting to note that now we can decide therapy based on cytogenetics. Also, that a number of CLL patients can be left untreated for long time, a large […]
More